In conclusion, AST/ALT ratio was found to be a useful prognostic predictor for CRPC patients, as it longitudinally reflects both cancer progression, such as development of metastasis and increased tumor volume, and biological aggressiveness from the time of PC diagnosis. Here, GOT1 is linked to pachyonychia congenita.